Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Jacobs

Showing results (41-50 of 264) with videos related to

Pageof 27
Sort By:
Journal of Clinical Microbiology|May 1, 1992
Evaluation of the 4-hour RapID NF Plus method for identification of 345 gram-negative nonfermentative rodsT T Kitch, M R Jacobs, P C Appelbaum
Journal of Clinical Microbiology|May 1, 1995
Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologiesS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|January 1, 1997
MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agentsS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|October 31, 1998
Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organismsG A Pankuch, M R Jacobs, P C Appelbaum
Drugs|January 1, 1995
Activity of DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and OPC-17116 against 112 penicillin-susceptible and -resistant pneumococciG A Pankuch, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|April 1, 1992
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacinS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|August 1, 1990
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centersP C Appelbaum, S K Spangler, M R Jacobs
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Activity of gemifloxacin, a new broad-spectrum quinolone, against 200 pneumococci by four different susceptibility testing methodsL M Ednie, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|September 1, 1994
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodologyG A Pankuch, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|June 1, 1997
Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobesS K Spangler, M R Jacobs, P C Appelbaum
Pageof 27

Showing results (41-50 of 264) with videos related to

Sort By:
Pageof 27
Journal of Clinical Microbiology|May 1, 1992
Evaluation of the 4-hour RapID NF Plus method for identification of 345 gram-negative nonfermentative rodsT T Kitch, M R Jacobs, P C Appelbaum
Journal of Clinical Microbiology|May 1, 1995
Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologiesS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|January 1, 1997
MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agentsS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|October 31, 1998
Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organismsG A Pankuch, M R Jacobs, P C Appelbaum
Drugs|January 1, 1995
Activity of DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and OPC-17116 against 112 penicillin-susceptible and -resistant pneumococciG A Pankuch, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|April 1, 1992
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacinS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|August 1, 1990
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centersP C Appelbaum, S K Spangler, M R Jacobs
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Activity of gemifloxacin, a new broad-spectrum quinolone, against 200 pneumococci by four different susceptibility testing methodsL M Ednie, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|September 1, 1994
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodologyG A Pankuch, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|June 1, 1997
Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobesS K Spangler, M R Jacobs, P C Appelbaum
Pageof 27